The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Consulting or Advisory Role - Epizyme; Lilly
Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa).
 
Andrew J. Wagner
Consulting or Advisory Role - Five Prime Therapeutics; Lilly; Loxo
Research Funding - AADi (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)
 
Richard F. Riedel
Employment - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Leadership - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Stock and Other Ownership Interests - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Consulting or Advisory Role - Daiichi Sankyo; Eisai; GlaxoSmithKline; Ignyta; Lilly; Loxo; Merck; Novartis
Research Funding - AADi (Inst); Agios (Inst); Arog (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; EMD Serono; Ignyta; Janssen
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
Research Funding - Merck; Pfizer
Expert Testimony - Me1 Patient
 
Rashmi Chugh
Stock and Other Ownership Interests - Portola Pharmaceuticals
Consulting or Advisory Role - EMD Serono; Epizyme; Janssen
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Biomarin (Inst); Epizyme (Inst); Lilly (Inst); MabVax (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst)
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Immune Design; Janssen; Novartis
 
Lee D. Cranmer
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - Amgen; Bristol-Myers Squibb; CytRx Corporation; GlaxoSmithKline; Merck; Prometheus; Threshold Pharmaceuticals
 
Seth Pollack
Consulting or Advisory Role - Amgen; Lilly; Nektar; Omeros
Research Funding - EMD Serono (Inst); Epizyme (Inst); Immune Design (Inst); Janssen Oncology; Karyopharm Therapeutics (Inst); Lilly/ImClone (Inst); Merck (Inst); OncoSec; Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Lilly/ImClone
 
Kamalesh Kumar Sankhala
Research Funding - AADi
 
Erlinda Maria Gordon
Research Funding - AADi
 
Vinod Ravi
No Relationships to Disclose
 
Jason L. Hornick
No Relationships to Disclose
 
David J. Kwiatkowski
Consulting or Advisory Role - AstraZeneca; Genentech/Roche
Research Funding - AADi
 
Berta Grigorian
No Relationships to Disclose
 
Neil Desai
Employment - AADi
Leadership - AADi
Stock and Other Ownership Interests - AADi
 
Mark Andrew Dickson
Consulting or Advisory Role - Celgene
Research Funding - Lilly